Here is a question worth asking yourself before you bring anything up at home: could you explain TMS in two sentences? If not, you are in the majority. And if you want to help a partner whose depression has not lifted on medication, being able to explain it plainly may be one of the more useful things you can do.
This guide walks through what transcranial magnetic stimulation is, what a course looks like from the first call to the last session, and where a spouse or partner fits in. It is not medical advice. It is the explanation most families never get.
Why so few people can explain it
In a survey we ran with 443 adults across ten Midwest states, one person in four said they know what TMS is. The exact figure, in the final validated data, was 25 percent, a small group.
What makes that striking is how many people said the core feature of TMS, that it does not involve medication, would matter to them. More than six in ten, 64 percent, cared about having a drug-free option. Households tied to a veteran or first responder through a spouse, parent or other relative, 156 respondents, put the drug-free share higher, at 72 percent. A further 25 percent did not know TMS and said drug-free did not matter to them, and 12 percent knew TMS but said drug-free made little difference to them. The biggest single group was people who care about drug-free care and have never heard of the treatment built around it.
The two-sentence version
If you want something short enough to say out loud, try this:
TMS is a treatment where a magnetic coil placed against the head sends pulses into a mood-regulating part of the brain. You stay awake, no medication is involved, and the FDA has cleared it for depression that antidepressants haven't improved.
That is accurate and it is enough to start a conversation. Everything else is detail your partner's clinician can fill in.
The longer version, step by step
The referral. It usually starts with a primary care doctor or psychiatrist who knows the history. They confirm a diagnosis of major depression, note which medications have been tried, and refer to a TMS provider. Insurance plans that cover TMS commonly want this documentation before approving it.
The evaluation. The TMS provider screens for anything that would make the treatment unsafe. Metal implanted in or near the head, certain devices, and a history of seizures are among the things they ask about. This is also when they check benefits and file for prior authorization if needed.
The mapping session. At the first treatment, a clinician finds the right spot on the head and the right strength for that person. This visit tends to take longer than later ones.
The course. A standard course often means a session on each weekday for about four to six weeks. Depending on the protocol, a session can be a few minutes long or close to an hour. The person sits in a reclining chair. The coil makes a tapping or clicking sound, and many people wear earplugs.
Afterward. Most people drive themselves home and go back to their day. The side effects people mention most are scalp soreness and headache, which often ease over the first couple of weeks. Seizures, though rare, are serious, and that is what the screening step guards against.
Checking progress. Clinicians usually track symptoms with standard questionnaires throughout the course. Some people notice changes partway through. Others do not respond. There is no certainty either way.
What TMS is not
It helps to have a few clear boundaries ready, because partners often hear TMS lumped in with other things.
- It is not ECT. Electroconvulsive therapy uses anesthesia and a brief induced seizure. TMS uses neither.
- It is not esketamine. Spravato, the esketamine nasal spray, counts as a drug; the FDA approved it for depression that keeps holding on after standard medicines, with every dose watched over at a certified clinic. Some people may benefit from it all the same. Brain Recovery Centers covers how Spravato visits are supervised if you want to compare.
- It is not at-home ketamine. Home-use ketamine products lack FDA approval for depression. They are a separate and less regulated category.
- It is not a quick fix. Several weeks of near-daily visits is a real commitment.
Where a partner fits
You will probably not be the one who talks your partner into anything. In our survey, a nudge from a friend or relative was enough for 18 percent, and 74 percent said the deciding voice would be their own doctor. That is a useful reality check. Your influence is real, but the clinician holds most of it.
So the most helpful role is often practical:
- Know the two-sentence version so you can answer "what is that?" without fumbling.
- Help write down the medication history: names, doses, how long each was tried, and what happened.
- Look at the weekly calendar with your partner. A daily course means someone may need to shift childcare, work hours, or shared car use.
- Ask your partner whether they want you at the first appointment, and respect the answer.
Distance and money come up quickly. Among our respondents, 43 percent listed a nearby provider and 85 percent listed insurance coverage among their two biggest priorities. For a daily treatment, both of those land on the household, not just the patient.
A note of honesty
TMS will not be right for everyone, and some people will not respond to it. The point of explaining it is not to sell it. It is so that when your partner says they want something other than another pill, the two of you know there is at least one more question to ask their doctor.
If your partner has mentioned suicide, or their safety worries you, act now rather than later. Counselors on the Suicide and Crisis Lifeline answer 988 by phone or text, at any hour, and partners are welcome to use it too.
Methodology
The survey was our publisher's project and expense; Pollfish put it before its consumer panel, and when it wrapped up on June 23, 2026, 443 respondents between 18 and 64 had finished, living in Minnesota, Missouri, Kansas, Ohio, Wisconsin, Iowa, Indiana, Oklahoma, Illinois, and Nebraska. The figures are final, published after Pollfish's validation.